NCT05723874View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

May 26, 2023

Study Completion Date

May 26, 2023

Conditions
Healthy
Interventions
DRUG

BI 425809

BI 425809

DRUG

Bosentan

Bosentan

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05723874 - A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood | Biotech Hunter | Biotech Hunter